omalizumab

Rilzabrutinib Reduces Itch and Hives in Antihistamine-Resistant Chronic Spontaneous Urticaria

by

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab demonstrated efficacy and a rapid onset of action with rilzabrutinib. | Image Credit: kanachaifoto – stock.adobe.com Rilzabrutinib demonstrated significant efficacy and a rapid onset of action in alleviating itch and hives in patients with moderate to severe chronic spontaneous urticaria (CSU) whose … Read more

Omalizumab Linked to Greatest Rate of Hypersensitivity Reactions in Atopic Diseases

by

Valerie Jaroenpuntaruk, MD Credit: the Mayo Clinic A retrospective cohort study, presented at the 2025 American Academy of Allergy, Asthma, & Immunology (AAAAI) annual meeting in San Diego from February 28 – March 8, reported the severity and the prevalence of hypersensitivity reactions to specific biologics for atopic diseases.1 Biologics have transformed the treatment of … Read more